HCAT
Health Catalyst Inc

818
Mkt Cap
$90.51M
Volume
894,843.00
52W High
$5.06
52W Low
$1.04
PE Ratio
-0.49
HCAT Fundamentals
Price
$1.23
Prev Close
$1.22
Open
$1.20
50D MA
$1.94
Beta
1.67
Avg. Volume
1.03M
EPS (Annual)
-$2.55
P/B
0.36
Rev/Employee
$259,280.00
$242.56
Loading...
Loading...
News
all
press releases
Health Catalyst (NASDAQ:HCAT) Earns Equal Weight Rating from Wells Fargo & Company
Wells Fargo & Company restated an "equal weight" rating and set a $1.00 price target (down from $5.00) on shares of Health Catalyst in a research note on Wednesday...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Health Catalyst, Inc. (NASDAQ:HCAT) Short Interest Up 18.1% in February
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) saw a significant increase in short interest in the month of February. As of February 27th, there was short interest totaling 6,750,287 shares...
MarketBeat·6d ago
News Placeholder
Health Catalyst, Inc. $HCAT is First Light Asset Management LLC's 7th Largest Position
First Light Asset Management LLC raised its stake in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 9.9% during the third quarter, according to the company in its most recent Form 13F filing...
MarketBeat·7d ago
News Placeholder
Health Catalyst, Inc. (NASDAQ:HCAT) Given Consensus Recommendation of "Hold" by Brokerages
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has earned an average recommendation of "Hold" from the thirteen ratings firms that are currently covering the stock, MarketBeat reports. One...
MarketBeat·8d ago
News Placeholder
Citigroup Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $1.75
Citigroup lowered their price target on Health Catalyst from $2.75 to $1.75 and set a "neutral" rating for the company in a report on Friday...
MarketBeat·9d ago
News Placeholder
Health Catalyst (NASDAQ:HCAT) Given New $2.00 Price Target at Stephens
Stephens reduced their price target on Health Catalyst from $3.50 to $2.00 and set an "equal weight" rating on the stock in a research report on Friday...
MarketBeat·10d ago
News Placeholder
Stifel Nicolaus Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $2.00
Stifel Nicolaus lowered their target price on shares of Health Catalyst from $3.75 to $2.00 and set a "hold" rating on the stock in a report on Friday...
MarketBeat·10d ago
News Placeholder
Health Catalyst Q4 Earnings Call Highlights
Health Catalyst (NASDAQ:HCAT) executives used the company's fourth-quarter and full-year 2025 earnings call to outline a leadership transition, discuss the financial impact of continued restructuring...
MarketBeat·10d ago
News Placeholder
Health Catalyst (HCAT) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·10d ago
News Placeholder
Health Catalyst (HCAT) Lags Q4 Earnings Estimates
Health Catalyst (HCAT) delivered earnings and revenue surprises of -14.26% and +1.45%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago
<
1
2
...
>

Latest HCAT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.